Yet, the effect of structural modifications on the neuroprotective activity of resveratrol in the insulin resistance-associated neurodegenerative processes remains unclear, as few studies have evaluated the efficacy of resveratrol analogs in AD-relevant in vitro models [24,25]. The gene discussed is INS; the disease is Alzheimer disease.